be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the

2017 compared to Q4 2016: Q4 2017 Q4 2016 YoY change YoY % change Unit: Million Thai Baht (THB) Sales and service income 209.13 181.21 27.92 15% Gain from exchange rate 0.44 0.57 -0.13 -23% Other income

which mainly due to commission income increased Baht 0.3 million and increased gain on exchange rate at Baht 0.1 million. For this year, as said, the gain on exchange rate at Baht 0.1 million while prior

Company and its subsidiaries consists of agent fee income, interest income, gain on exchange rate and gain on short-term investment. For the three-month period ended 31 March 2019, other income totaled THB

0.73 million Baht and 2.12 million Baht, which were sales of scrap materials, interest income, gain on changes in fair value of short-term investment, and gain on exchange rates, etc. The other income

(16.38) (15.75) Cost of sales of goods 81.76 78.62 68.69 78.40 (13.07) (15.99) Gross profit 22.23 21.38 18.92 21.60 (3.31) (14.89) Other income 1.32 1.27 1.07 1.22 (0.25) (18.93) Gain on exchange rate

million which mainly due to commission income increased Baht 4.2 million and increased gain on exchange rate at Baht 2 million and income received from commission increased Baht 1.1 million For this year

domestic sales of 99.49 percent of total revenue from sales and services. 1.2 Other income Other income consists of interest income, gain from asset sales and revenue from scrap sales. For the year ended

Company and its subsidiaries booked net exchange gain of Baht 2.81 million and revenue from concrete and steel products as other incomes in the third quarter of 2018 (3) Cost of sales The Company and its

-recurring items 135.5 18.9 (3.3) (0.2) (102.4%) 1 Adjusted EBITDA for any year/period is defined as Profit (loss) before income taxes plus Finance costs, plus Depreciation and Amortization, deduct (plus) gain